The Welsh laboratory specializes in the development and application of computational tools for predictive toxicology and pharmaceutical drug discovery. Dr. Welsh’s publication record currently includes over 400 articles in peer-reviewed books and journals, over 600 abstracts from presentations at professional scientific meetings, and over 40 patents and patent applications.  He is the recipient of multiple awards and honors, including the Teacher of the Year Award (1983 and 1985), the St. Louis Research Award (1998), the University of Missouri-St. Louis Chancellor’s Research and Creativity Award (2001), the University of Missouri Entrepreneur of the Year Award (2001), the Norman H. Edelman Endowed Professorship in Bioinformatics at UMDNJ-RWJMS (2003), the John C. Krantz Jr. Award (2004), and the Honorary Society Plenary Lectureship, Georgia State University (2009).  He serves on the advisory boards of several scientific journals.  Dr. Welsh earned a B.S. degree in Chemistry from St. Joseph’s University (Phila., PA) in 1969 and a Ph.D. degree in Theoretical Physical Chemistry in 1975 from the University of Pennsylvania (Phila., PA).  He also held postdoctoral appointments at the University of Cincinnati (OH) and the National Institutes of Health (NIH).   In 2012-13, Dr. Welsh took a sabbatical leave in the Department of Chemistry at Princeton University where he maintains a position as Visiting Faculty Scholar.  In 2007, Dr. Welsh founded Snowdon Inc. (Monmouth Junction, NJ), a start-up company that specializes in cheminformatics tools and techniques and in the discovery and development of therapeutic agents for the treatment of cancer, pain, and infectious diseases.